GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Biotest AG (XTER:BIO3) » Definitions » Dividend Payout Ratio

Biotest AG (XTER:BIO3) Dividend Payout Ratio : 0.00 (As of Sep. 2024)


View and export this data going back to 1987. Start your Free Trial

What is Biotest AG Dividend Payout Ratio?

The Dividend Payout Ratio is the measure of dividends paid out to shareholders relative to the company's net income. It is calculated as the Dividends per Share divided by the Earnings per Share (Diluted) during the same time period. Biotest AG's Dividend Payout Ratio for the months ended in Sep. 2024 was 0.00.

The historical rank and industry rank for Biotest AG's Dividend Payout Ratio or its related term are showing as below:

XTER:BIO3' s Dividend Payout Ratio Range Over the Past 10 Years
Min: 0.01   Med: 0.24   Max: 0.4
Current: 0.02


During the past 13 years, the highest Dividend Payout Ratio of Biotest AG was 0.40. The lowest was 0.01. And the median was 0.24.

XTER:BIO3's Dividend Payout Ratio is ranked better than
99.29% of 140 companies
in the Biotechnology industry
Industry Median: 0.48 vs XTER:BIO3: 0.02

As of today (2024-12-14), the Dividend Yield % of Biotest AG is 0.15%.

During the past 13 years, the highest Trailing Annual Dividend Yield of Biotest AG was 1.46%. The lowest was 0.07%. And the median was 0.18%.

Biotest AG's Dividends per Share for the months ended in Sep. 2024 was €0.00.

During the past 13 years, the highest 3-Year average Dividends Per Share Growth Rate of Biotest AG was 39.30% per year. The lowest was -50.70% per year. And the median was 12.20% per year.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.

* Please note that "special dividend" is not included in the calculation of dividend per share and related fields.


Biotest AG Dividend Payout Ratio Historical Data

The historical data trend for Biotest AG's Dividend Payout Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biotest AG Dividend Payout Ratio Chart

Biotest AG Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Dividend Payout Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Biotest AG Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Dividend Payout Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - 0.17 -

Competitive Comparison of Biotest AG's Dividend Payout Ratio

For the Biotechnology subindustry, Biotest AG's Dividend Payout Ratio, along with its competitors' market caps and Dividend Payout Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Biotest AG's Dividend Payout Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Biotest AG's Dividend Payout Ratio distribution charts can be found below:

* The bar in red indicates where Biotest AG's Dividend Payout Ratio falls into.



Biotest AG Dividend Payout Ratio Calculation

The Dividend Payout Ratio is the measure of dividends paid out to shareholders relative to the company's net income. It is calculated as the Dividends per Share divided by the Earnings per Share (Diluted) during the same time period.

Biotest AG's Dividend Payout Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Dividend Payout Ratio=Dividends per Share (A: Dec. 2023 )/ EPS without NRI (A: Dec. 2023 )
=0/ 2.721
=0.00

Biotest AG's Dividend Payout Ratio for the quarter that ended in Sep. 2024 is calculated as

Dividend Payout Ratio=Dividends per Share (Q: Sep. 2024 )/ EPS without NRI (Q: Sep. 2024 )
=0/ -0.25
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Biotest AG (XTER:BIO3) Dividend Payout Ratio Explanation

In dividends investing, Dividend Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.


Biotest AG Dividend Payout Ratio Related Terms

Thank you for viewing the detailed overview of Biotest AG's Dividend Payout Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Biotest AG Business Description

Traded in Other Exchanges
Address
Landsteinerstrasse 5, Dreieich, DEU, 63303
Biotest AG is a supplier of biological medicines. The company produces its products from human blood plasma or manufactured by using biotechnology methods. It is engaged in the area of hematology, clinical immunology, and intensive care medicine. The operating business segments are Therapy, Plasma and Services, and Other segments. It generates maximum revenue from the Therapy segment. Geographically, it derives a majority of revenue from Central Europe and also has a presence in other countries.
Executives
Dr. Katrin Bernöster Vice President Corp. Project + Portfolio Management
Dr. Martin Reinecke Senior Vice President plasma alliances and proteine supply
Stephan Fleck Vice President Corporate Controlling
Dr. Jörg Schüttrumpf VP Corp. Research &Development
Michael Moritz VP CC Materials & Facility Management

Biotest AG Headlines

No Headlines